JP Morgan Chase’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-100,000
Closed -$15.7M – 7460
2025
Q3
$15.7M Buy
+100,000
New +$15.4M ﹤0.01% 2302
2023
Q1
– Sell
-13,300
Closed -$1.02M – 6722
2022
Q4
$1.02M Buy
13,300
+4,400
+49% +$334K ﹤0.01% 4021
2022
Q3
$593K Hold
8,900
– – ﹤0.01% 4347
2022
Q2
$465K Hold
8,900
– – ﹤0.01% 4610
2022
Q1
$505K Sell
8,900
-7,500
-46% -$402K ﹤0.01% 4686
2021
Q4
$844K Hold
16,400
– – ﹤0.01% 4507
2021
Q3
$811K Buy
+16,400
New +$890K ﹤0.01% 4454
2018
Q1
– Sell
-25,900
Closed -$1.59M – 5394
2017
Q4
$1.59M Hold
25,900
– – ﹤0.01% 3449
2017
Q3
$1.74M Buy
+25,900
New +$1.83M ﹤0.01% 3240

Other funds holding CAH

JP Morgan Chase's CAH Position: Q2 2026 in Review

JP Morgan Chase increased its Cardinal Health (CAH) stake by 15% in Q2 2026, buying an estimated $73.2M and bringing the position to 2,668,749 shares worth $630M. The position accounts for 0.03% of the portfolio, ranked #395.

JP Morgan Chase first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. 1,501 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • JP Morgan Chase held 2,668,749 shares of Cardinal Health worth $630M as of Q2 2026.
  • JP Morgan Chase bought 352,105 Cardinal Health shares in Q2 2026, an estimated $73.2M.
  • Cardinal Health made up 0.03% of JP Morgan Chase's portfolio in Q2 2026, its #395 holding.
  • JP Morgan Chase first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
  • 1,501 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.